Comments
The country’s Covid-19 mortality numbers saw a steep increase yesterday because of a revision from Bihar. But that’s not necessarily a bad thing.
As another home-use kit gets approved , will it keep people from rushing to testing Centres or are the high false negatives a draw back? Experts weigh in.
Meanwhile, Tamil Nadu stays cautious, extends its lockdown .
In a worrying find, reinfections are seen among healthcare workers in the Capital. Though the study had limited scope, it calls for a larger investigation.
And the alliances on Covid-drugs continues , this time on Merck drug molnupiravir.
The Biden administration’s commitment to supply Pfizer vaccines was announced as expected. About 200 million of the 500 million will be delivered by later this year.
As the need for masks looks unlikely to go away, just yet – here’s one hybrid, washable model .
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.